SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001123292-20-000792
Filing Date
2020-05-26
Accepted
2020-05-26 16:30:43
Documents
1
Group Members
MSD CREDIT OPPORTUNITY MASTER FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 plxpharma13g_05262020.htm SC 13G 233757
  Complete submission text file 0001123292-20-000792.txt   235606
Mailing Address 9 FISHERS LANE SUITE E SPARTA NJ 07871
Business Address 9 FISHERS LANE SUITE E SPARTA NJ 07871 (713) 842-1249
PLx Pharma Inc. (Subject) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 0515
Type: SC 13G | Act: 34 | File No.: 005-88072 | Film No.: 20911029
SIC: 2834 Pharmaceutical Preparations

Mailing Address 645 FIFTH AVENUE 21ST FLOOR NEW YORK NY 10022
Business Address 645 FIFTH AVENUE 21ST FLOOR NEW YORK NY 10022 (212) 303-1650
MSD Partners, L.P. (Filed by) CIK: 0001514334 (see all company filings)

IRS No.: 271522220 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G